EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Placental Dysfunction Is Associated with Dysregulated Fibrinolytic System Activation

Tetiana Yatsenko iD, Iryna Us iD, Daria Korolova iD, Svitlana Zhuk iD, Halyna Dziuba, Alona Nalbat iD, Svitlana Kharchenko iD, Sandor George Vari iD, Volodymyr Chernyshenko iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tetiana Yatsenko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Palladin Institute of Biochemistry of NAS of Ukraine, 01054 Kyiv, Ukraine. Hauptthemen laut MEDLINE: Fibrinolysis, Placenta, Placental Insufficiency. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cedars-RECOOP Solidarity Fellowship, European Fund for Displaced Scientists, Cedars–RECOOP Solidarity Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During pregnancy, the maternal hemostatic system undergoes significant changes to support placental angiogenesis, maintain fetal blood flow, and ensure safe delivery. This study investigates the dysregulation of hemostasis in placental insufficiency and explores potential markers for diagnosing and managing this gestational complication. Thromboelastography, coagulation and fibrinolysis functional assays, ELISA, and immunoblotting were employed to assess hemostasis dysregulation in placental dysfunction of two cohorts of pregnant women with placental dysfunction and healthy controls. Thromboelastographic analysis revealed no significant differences in clot lysis indices between the control and placental dysfunction groups, with values remaining within normal ranges, suggesting this method’s limitations for assessing fibrinolysis in pregnancy. The placental dysfunction group demonstrated moderately increased fibrinogen levels and platelet sensitivity to ADP, indicating hemostasis reactiveness. Significantly lower D-dimer levels, decreased plasminogen activator inhibitor activity (total PAI-1 + PAI-2), and increased plasminogen activator activity, driven primarily by uPA in the placental dysfunction group, indicated abnormal fibrinolysis. Immunoblotting confirmed elevated uPA/uPA-PAI complexes and reduced tPA/tPA-PAI complexes, indicating that shutdown of tPA-mediated fibrinolysis and induction of uPA-driven vessel-wall-associated proteolysis are linked to placental dysfunction. Placental dysfunction involves fibrinolytic system dysregulation, marked by decreased PAI and tPA, uPA overproduction, and hypofibrinolysis, contributing to thrombotic risks, impaired placental flow, and complications like fetal growth retardation. PAI/PA ratio and D-dimer levels have diagnostic potential for placental-dysfunction-associated complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinolysisPlacentaPlacental InsufficiencyFemalePregnancyHumansAdultThrombelastographyTissue Plasminogen ActivatorBiomarkersBlood CoagulationPlasminogen Activator Inhibitor 1Fibrin Fibrinogen Degradation ProductsHemostasis

Stichwörter der Autor:innen

bleedingfibrinolysishemostasisplacental dysfunctionthrombosis

Substanzen

Tissue Plasminogen ActivatorBiomarkersPlasminogen Activator Inhibitor 1Fibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

  • Palladin Institute of Biochemistry of NAS of Ukraine, 01054 Kyiv, Ukraine.
  • Shupyk National Healthcare University of Ukraine, 04112 Kyiv, Ukraine.
  • Kyiv Perinatal Center, 03150 Kyiv, Ukraine.
  • International Research and Innovation in Medicine Program, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

ORCID-Profile: Tetiana Yatsenko, Iryna Us, Daria Korolova, Svitlana Zhuk, Alona Nalbat, Svitlana Kharchenko, Sandor George Vari, Volodymyr Chernyshenko

Förderung

  • Cedars-RECOOP Solidarity Fellowship
  • European Fund for Displaced Scientists
  • Cedars–RECOOP Solidarity Fellowship
  • European Federation of Academies of Sciences and Humanities

Zitieren

APA

Yatsenko, T., Us, I., Korolova, D., Zhuk, S., Dziuba, H., Nalbat, A., Kharchenko, S., Vari, S. G., & Chernyshenko, V. (2025). Placental Dysfunction Is Associated with Dysregulated Fibrinolytic System Activation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199339

Vancouver

Yatsenko T, Us I, Korolova D, Zhuk S, Dziuba H, Nalbat A, et al. Placental Dysfunction Is Associated with Dysregulated Fibrinolytic System Activation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199339

BibTeX
@article{Yatsenko2025,
  author = {Yatsenko, Tetiana and Us, Iryna and Korolova, Daria and Zhuk, Svitlana and Dziuba, Halyna and Nalbat, Alona and Kharchenko, Svitlana and Vari, Sandor George and Chernyshenko, Volodymyr},
  title = {Placental Dysfunction Is Associated with Dysregulated Fibrinolytic System Activation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199339}
}
Kostenlos starten →